Trial Profile
A 2 part study investigating efficacy of Lenalidomide and dexamethasone in patients with multiple myeloma as a second line therapy .
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Betamethasone; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms The REVII trial
- 21 Dec 2015 New trial record
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology